BlackRock sees Healthcare as the next major AI winner: Why Thermo Fisher, IQVIA, and Medpace could benefit

The next major AI-winning industry might not lie in the technology sector but in healthcare. BlackRock has analyzed over 1,000 corporate reports and sees substantial productivity potential, particularly in drug development. A new drug typically requires about ten years of development time and approximately 2 billion USD in investment. Even moderate improvements in success rates and development times could significantly enhance the returns of pharmaceutical research. This is exactly why we are already focusing on this, which is why BB Biotech, Medpace,...